AB668, a novel highly selective protein kinase CK2 inhibitor with a distinct anti-tumor mechanism as compared to CX-4945 and SGC-CK2-1

Alexandre Bancet(Université Claude Bernard Lyon 1), Isabelle Krimm(Université Claude Bernard Lyon 1)
bioRxiv (Cold Spring Harbor Laboratory)
December 16, 2022
Cited by 2


Related Papers